Quick Takeaways: Why It Matters? Bond Vet is layering a simple membership on top of its clinics to nudge clients into more frequent, preventative visits while locking in long‑term relationships. The limited-time Founding Member offer (100 dollars off enrolment from April ...
Quick Takeaways: Why It Matters? Elanco is extending its Advantage franchise into the collar segment with an over‑the‑counter, one‑size, water‑resistant dog collar that kills fleas and ticks and repels mosquitoes for four months, meaning most pets need only three collars per ye...
Quick Takeaways: Why It Matters? Chewy is using the Modern Animal acquisition to bolt a fast-growing, tech-enabled clinic network onto its retail, pharmacy, and insurance stack, expanding Chewy Vet Care from 18 to 47 locations and adding over 125 million dollars in hi...
Quick Takeaways: Why It Matters? Parnell is bolstering its US footprint by buying Noble Pharma, adding an FDA and DEA‑accredited plant in Wisconsin with broad dosage-form capabilities to secure supply and support portfolio growth. The acquisition turns Noble’s CDMO-style ...
Quick Takeaways: Why It Matters? Petwealth is positioning itself as an at‑home diagnostics and data layer for pet health, bundling fecal, oral, and respiratory PCR into a single kit and pairing 24–48‑hour lab results with AI‑generated insights and 24/7 tele-vet suppor...
Quick Takeaways: Why It Matters? IFF is using PureStrong to push a dog-first probiotic paradigm—built on a single, canine-derived Limosilactobacillus reuteri strain, into a fast-growing, 3.2 billion dollar US pet supplement market that is stil...
Quick Takeaways: Why It Matters? nixiFLOR gives vets and producers a lower‑cost, first‑generic alternative to Resflor Gold with the same florfenicol–flunixin combo and FDA‑confirmed bioequivalence for BRD treatment and BRD‑associated fever in beef and non‑l...
Shots: Why It Matters? IDEXX is extending its Cancer Dx platform into the UK, giving vets a blood-based panel that can be added to wellness profiles and delivers lymphoma results in 3–5 days with 79% sensitivity and 99% specificity. With real-world use in roughly 6,...
Shots: Why It Matters? Designating Wamego as its global HQ formalizes Axiota’s shift from a product-focused business to an integrated innovation hub, anchoring manufacturing, R&D, and scientific operations in the heart of the KC Animal Health Corridor n...
Quick Takeaways: Why It Matters? Piclidenoson’s Phase 2 enrollment milestone, fully funded by Vetbiolix, moves this A3 adenosine receptor agonist closer to potential registration as a chronic oral osteoarthritis option in dogs, with LOAD, VAS, and ...
